Pickard Susan, Marshall Martin, Rogers Anne, Sheaff Rod, Sibbald Bonnie, Campbell Stephen, Halliwell Shirley, Roland Martin
National Primary Care Research and Development Centre, University of Manchester, Manchester, UK.
Health Expect. 2002 Sep;5(3):187-98. doi: 10.1046/j.1369-6513.2002.00175.x.
To investigate the involvement of users in clinical governance activities within Primary Care Groups (PCGs) and Trusts (PCTs). Drawing on policy and guidance published since 1997, the paper sets out a framework for how users are involved in this agenda, evaluates practice against this standard and suggests why current practice for user involvement in clinical governance is flawed and why this reflects a flaw in the policy design as much as its implementation.
Qualitative data comprising semi-structured interviews, reviews of documentary evidence and relevant literature.
Twelve PCGs/PCTs in England purposively selected to provide variation in size, rurality and group or trust status.
Key stakeholders including Lay Board members (n = 12), Chief Executives (CEs) (n = 12), Clinical Governance Leads (CG leads) (n = 14), Mental Health Leads (MH leads) (n = 9), Board Chairs (n = 2) and one Executive Committee Lead.
Despite an acknowledgement of an organizational commitment to lay involvement, in practice very little has occurred. The role of lay Board members in setting priorities and implementing and monitoring clinical governance remains low. Beyond Board level, involvement of users, patients of GP practices and the general public is patchy and superficial. The PCGs/PCTs continue to rely heavily on Community Health Councils (CHCs) as a conduit or substitute for user involvement; although their abolition is planned, their role to be fulfilled by new organizations called Voices, which will have an expanded remit in addition to replacing CHCs.
Clarity is required about the role of lay members in the committees and subcommittees of PCGs and PCTs. Involvement of the wider public should spring naturally from the questions under consideration, rather than be regarded as an end in itself.
调查初级保健小组(PCG)和初级保健信托(PCT)中用户参与临床治理活动的情况。本文依据1997年以来发布的政策和指南,阐述了用户参与该议程的框架,对照此标准评估了实践情况,并指出当前用户参与临床治理的实践存在缺陷的原因,以及这为何既反映了政策设计上的缺陷,也反映了政策实施过程中的缺陷。
定性数据,包括半结构化访谈、文献证据回顾及相关文献。
英格兰的12个PCG/PCT,经过特意挑选以确保在规模、乡村程度以及小组或信托状态方面具有多样性。
关键利益相关者,包括非专业董事会成员(n = 12)、首席执行官(CE)(n = 12)、临床治理负责人(CG负责人)(n = 14)、心理健康负责人(MH负责人)(n = 9)、董事会主席(n = 2)以及一名执行委员会负责人。
尽管承认在组织层面致力于让非专业人员参与,但实际上进展甚微。非专业董事会成员在确定优先事项、实施和监督临床治理方面的作用仍然有限。在董事会层面之外,用户、全科医生诊所的患者以及普通公众的参与零散且肤浅。PCG/PCT仍然严重依赖社区健康委员会(CHC)作为用户参与的渠道或替代;尽管计划废除CHC,但它们的角色将由名为“声音”的新组织来履行,该组织除了取代CHC之外,还将有更广泛的职责。
需要明确非专业成员在PCG和PCT的委员会及小组委员会中的角色。更广泛公众的参与应自然地源于所考虑的问题,而不应将其本身视为目的。